ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.496,79
0,12%
S&P 500
5.235,48
-0,60%
Dow Jones
38.111,48
-0,86%
Euro vs US Dollar
1,08193
-0,11%
Bitcoin
68.595,29
0,34%
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NYSE
  6. Ginkgo Bioworks Holdings Inc (DNA)

  7. Ginkgo Bioworks Holdings Inc (DNA) News

DNA

Ginkgo Bioworks (DNA)

Ginkgo Bioworks Holdings Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NYSE:DNA
DatumZeitQuelleÜberschriftSymbolFirma
30/05/202416h58Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:DNAGinkgo Bioworks Holdings Inc
29/05/202416h45Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:DNAGinkgo Bioworks Holdings Inc
28/05/202416h18Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:DNAGinkgo Bioworks Holdings Inc
24/05/202416h22Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:DNAGinkgo Bioworks Holdings Inc
23/05/202416h02Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:DNAGinkgo Bioworks Holdings Inc
22/05/202415h44Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:DNAGinkgo Bioworks Holdings Inc
21/05/202417h02Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:DNAGinkgo Bioworks Holdings Inc
20/05/202416h43Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:DNAGinkgo Bioworks Holdings Inc
20/05/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNYSE:DNAGinkgo Bioworks Holdings Inc
17/05/202422h50Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NYSE:DNAGinkgo Bioworks Holdings Inc
17/05/202416h24Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:DNAGinkgo Bioworks Holdings Inc
17/05/202416h24Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:DNAGinkgo Bioworks Holdings Inc
17/05/202416h24Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:DNAGinkgo Bioworks Holdings Inc
16/05/202416h31Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:DNAGinkgo Bioworks Holdings Inc
15/05/202419h24Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:DNAGinkgo Bioworks Holdings Inc
15/05/202413h01PR Newswire (US)Ginkgo Bioworks to Participate in Two Conferences in MayNYSE:DNAGinkgo Bioworks Holdings Inc
15/05/202400h00PR Newswire (US)Sojitz Corporation and Ginkgo Bioworks Announce Plans to Use Synthetic Biology R&D Services to Accelerate Sustainable Manufacturing in JapanNYSE:DNAGinkgo Bioworks Holdings Inc
14/05/202416h48Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:DNAGinkgo Bioworks Holdings Inc
13/05/202422h14Edgar (US Regulatory)Form 8-K - Current reportNYSE:DNAGinkgo Bioworks Holdings Inc
13/05/202422h05PR Newswire (US)Ginkgo Bioworks Receives Continued Listing Standard Notice From NYSENYSE:DNAGinkgo Bioworks Holdings Inc
13/05/202416h50Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:DNAGinkgo Bioworks Holdings Inc
10/05/202416h10Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:DNAGinkgo Bioworks Holdings Inc
09/05/202423h16Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NYSE:DNAGinkgo Bioworks Holdings Inc
09/05/202422h11Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:DNAGinkgo Bioworks Holdings Inc
09/05/202422h02Edgar (US Regulatory)Form 8-K - Current reportNYSE:DNAGinkgo Bioworks Holdings Inc
09/05/202422h01PR Newswire (US)Ginkgo Bioworks Reports First Quarter 2024 Financial ResultsNYSE:DNAGinkgo Bioworks Holdings Inc
09/05/202416h13Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:DNAGinkgo Bioworks Holdings Inc
08/05/202416h43Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:DNAGinkgo Bioworks Holdings Inc
07/05/202417h40Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:DNAGinkgo Bioworks Holdings Inc
07/05/202413h01PR Newswire (US)GreenLab Partners with Ginkgo Bioworks to Scale Up Production of Brazzein, a Novel SweetenerNYSE:DNAGinkgo Bioworks Holdings Inc
 Showing the most relevant articles for your search:NYSE:DNA

Kürzlich von Ihnen besucht

USOTC
MICRD
Micron Solutions (CE)
EU
CAHBG
Credit Agricole Home Loa...
LSE
SH02
Pen Ins Corp.33
LSE
40HT
Nat.aus.bk.frn
BIT
UC5F1M
Unicredit Bank
TG
PA9
Travelers Companies
TG
28Y
High Liner Foods
COIN
BARRUSD
TSXV
IGO.A
USOTC
FLXT
Flexpoint Sensor Systems (PK)
TG
9GN
Generation Mining
TSXV
ODX.H
Odyssey Resources
BIT
UC8K3J
Unicredit Bank
TG
3ZT
Reynolds Consumer Products
COIN
CELCBTC
CelCoin
TG
P210
Common Stock
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten